Aktie A2DU6V CO-DIAGNOSTICS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Co-Diagnostics, Inc.

Aktien

A2DU6V

US1897631057

CODX

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:00:00 27.06.2024 		% 5 Tage % 1. Jan.
1,27 USD -4,51 % Intraday Chart für Co-Diagnostics, Inc. -12,41 % -4,51 %
14.06. Co-Diagnostics, Inc. reicht ersten FDA 510(k) Antrag für Co-Dx PCR Pro Plattform ein CI
13.05. CO-DIAGNOSTICS, INC. : HC Wainwright bleibt neutral ZM

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co Diagnostics : Submits First FDA 510(k) Application for Co Dx PCR Pro Platform Form 8 K
Co-Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
Co-Diagnostics, Inc. Appoints Executive Appointments
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England
Co-Diagnostics, Inc. Appoints Richard Abbott as President
Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2DU6V Aktie
  4. Nachrichten Co-Diagnostics, Inc.
  5. Andere Sprachen